Early progression of mantle cell lymphoma depicts a high-risk disease with poor response to subsequent therapies and a dismal outcome

c.w. Eskelund, A Kolstad, Ingrid Glimelius, R. Räty, Lise Mette Rahbek Gjerdrum, K. Sonnevi, Pär Josefsson, Herman Nilsson-Ehle, Hans Bentzen, Unn-Merete Fagerli, O. Kuittinen, Jacob Haaber Christensen, L.B. Pedersen, M.T. Larsen, C.H. Geisler, Martin Hutchings, M. erkeman , K. Grønbæk

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
TidsskriftHematological Oncology
Vol/bind37
Udgave nummerSuppl. 2
Sider (fra-til)242
Antal sider1
ISSN0278-0232
DOI
StatusUdgivet - 12. jun. 2019
Begivenhed15th International Conference on Malignant Lymphoma - Palazzo dei Congressi, Lugano, Schweiz
Varighed: 18. jun. 201922. jun. 2019

Konference

Konference15th International Conference on Malignant Lymphoma
LokationPalazzo dei Congressi
LandSchweiz
ByLugano
Periode18/06/201922/06/2019

Citationsformater

Eskelund, C. W., Kolstad, A., Glimelius, I., Räty, R., Gjerdrum, L. M. R., Sonnevi, K., Josefsson, P., Nilsson-Ehle, H., Bentzen, H., Fagerli, U-M., Kuittinen, O., Christensen, J. H., Pedersen, L. B., Larsen, M. T., Geisler, C. H., Hutchings, M., erkeman , M., & Grønbæk, K. (2019). Early progression of mantle cell lymphoma depicts a high-risk disease with poor response to subsequent therapies and a dismal outcome. Hematological Oncology, 37(Suppl. 2), 242. https://doi.org/10.1002/hon.52_2630